Eli Lilly and Company (LLY)

Pretax margin

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Earnings before tax but after interest (EBT) US$ in thousands 12,680,400 6,554,600 6,806,400 6,155,500 7,229,900
Revenue US$ in thousands 45,042,700 34,124,100 28,541,400 28,318,400 24,539,800
Pretax margin 28.15% 19.21% 23.85% 21.74% 29.46%

December 31, 2024 calculation

Pretax margin = EBT ÷ Revenue
= $12,680,400K ÷ $45,042,700K
= 28.15%

The pretax margin of Eli Lilly and Company has shown some fluctuations over the years, with a noticeable decline from 29.46% in December 31, 2020 to 19.21% in December 31, 2023. However, there was a recovery to 28.15% by December 31, 2024. This indicates that the company's profitability before taxes experienced some challenges but managed to improve towards the end of the period. It would be advisable to further investigate the factors contributing to these fluctuations to understand the underlying dynamics impacting Eli Lilly's financial performance.